Table 2.

Primers used in this study

Name	Sequence
Primer
hr5 U	5′-CGATAAGCTTACTAGCCTTTGTCATTGCTTGATTG-3′
hr5 L	5′-CTAGTGATTCCATAACGTCCGTTCGATTCAACGTA-3′
A3pro U	5′-GGATCCTAGGTGCGCGTTACCATATATG-3′
A3pro L	5′-GATATCCATGGTCTTGAATTAGTCTGCAAG-3′
SV40polyA U	5′-GATATCAGATCTCATAATCAGCCATACCA-3′
SV40polyA L	5′-GTCGACCTAGGATACATTGATGAGTTTGG-3′
Sersig U	5′-CCATGGAAATCAAAATGCGTTTCGTTCTGT-3′
SigBlaOE L	5′-CAAAGGCTTGGCCATGTGGTGACCGAAAGC-3′
SigBlaOE U	5′-GCTTTCGGTCACCACATGGCCAAGCCTTTG-3′
Bla L	5′-AGATCTCCCGGGACGTGTCAGTCCTGCTCC-3′
SerTATASerK U	5′-CTGCAGGCATGCAAGCTTGAGCTCGACCGC-3′
SerTATASerKOE L	5′-CACAGAACGAAACGCATGTTGGCGGTCTTT-3′
SerTATASerKOE U	5′-AAAGACCGCCAACATGCGTTTCGTTCTGTG-3′
Sersig L	5′-GCCTAGGGAGACGGCAGATCGTCTCCAGCTTTTACGCTGAGCGC-3′
EYFP U	5′-CCATGGAAATCAAAATGGTGAGCAAGGGCG-3′
EYFP L	5′-GCGGCCGCTTATCTAGATCCGGTGGATCCCGG-3′
AmCyan U	5′-CCATGGAAATCAAAATGGCCCTGTCCAACA-3′
AmCyan L	5′-GCGGCCGCTCAGAAGGGCACCACGGAGGTGAT-3′
Rituximab HC U	5′-GCGTCTCAAGCTCAGGTACAACTGCAGCAG-3′
Rituximab HC L	5′-GCGTCTCCCTAGTCATTTACCCGGAGACAG-3′
Rituximab LC U	5′-GCGTCTCAAGCTCAAATTGTTCTCTCCCAG-3′
Rituximab LC L	5′-GCGTCTCCCTAGCTAACACTCTCCCCTGTT-3′
adapter
PstI adapter	5′-CAGATCTGCTAGCCTCGAGCTGCA-3′
	3′-ACGTGTCTAGACGATCGGAGCTCG-5′